XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Mar. 31, 2022 $ 1,542 $ 147,460,747 $ (130,329,181) $ 0 $ (141,708) $ 16,991,400
Beginning balance, shares at Mar. 31, 2022 1,541,926          
Issuances of common stock for cash under at the market program $ 748 8,926,463 8,927,211
Issuances of common stock for cash under at the market program, shares 748,084          
Issuance of common shares upon vesting of restricted stock units and net stock option exercise $ 9 (12,502) (12,493)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 9,249          
Loss on dissolution of subsidiary 142,121 142,121
Stock-based compensation expense 1,051,898 1,051,898
Net loss (12,029,373) (413) (12,029,786)
Other comprehensive loss (6,141) (6,141)
Reversal of accrued commission liability (see Note 6)           0
Ending balance, value at Mar. 31, 2023 $ 2,299 157,426,606 (142,358,554) (6,141) 0 15,064,210
Ending balance, shares at Mar. 31, 2023 2,299,259          
Issuances of common stock for cash under at the market program $ 296 1,322,087 1,322,383
Issuances of common stock for cash under at the market program, shares 296,056          
Rounding for reverse split
Rounding for reverse split, shares 32          
Issuance of common shares upon vesting of restricted stock units $ 34 (34,812) (34,778)
Issuance of common stock upon vesting of restricted stock units, shares 34,378          
Stock-based compensation expense 1,219,370 1,219,370
Net loss (12,208,174) (12,208,174)
Other comprehensive loss (799) (799)
Reversal of accrued commission liability (see Note 6) 404,120 404,120
Ending balance, value at Mar. 31, 2024 $ 2,629 $ 160,337,371 $ (154,566,728) $ (6,940) $ 0 $ 5,766,332
Ending balance, shares at Mar. 31, 2024 2,629,725